To include your compound in the COVID-19 Resource Center, submit it here.
C.R. Bard began the single-blind, international Phase III Lutonix Below the Knee (BTK) trial to
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury